ST Kaili released its 2026 half-year report. First-half net profit attributable to the parent was 134 million yuan, up 205.7% year on year. Operating revenue was 360 million yuan, down 34.03% year on year. Net profit attributable to the parent excluding non-recurring items was 75.55 million yuan, up 123.8% year on year. Net operating cash flow was 91.27 million yuan, up 102.2% year on year. Second-quarter net profit attributable to the parent was 67.84 million yuan, up 207.6% year on year. The company's main business includes the production, research and development, sales and service of orthopedic implant medical devices. Its low-temperature radiofrequency energy platform business in the US market achieved significant growth and became an important incremental contributor to performance.
Shanghai Kinetic Medical CoFirst-half net profit attributable to parent up 205.7% year on year.
